Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the presentation of multiple abstracts demonstrating the clinical benefits of treatment with CFTR modulators, including the Company’s ...

The U.S. Food and Drug Administration has approved elinzanetant, a new non-hormonal treatment to help women manage menopause ...

Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...

After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...

That subtle dark line across the back of the neck might seem just a skin-matter. We might think it is because the clothes we ...

The U.S. Food and Drug Administration (FDA) has approved a new nonhormonal treatment to help women manage menopause symptoms ...

Background/Aims The neuroprotective effect of nicotinamide (NAM) supplementation has been demonstrated in both animal models ...

BRIUMVI is currently approved in the United States, as well as several countries outside of the U.S., as a one-hour intravenous (IV) infusion administered twice a year, following the starting dose, in ...

TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in the randomized cohort of the Phase 3 ENHANCE trial evaluating a consolidated ...

Here’s what one woman wants others to know about moving forward with strength and hope after an early breast cancer diagnosis ...

UnitedHealth Group (NYSE: UNH) reported third quarter 2025 results, reflecting the continued execution on its performance agenda, refocus on its ...

Merck Announces KEYTRUDA Plus WELIREG Met Primary Endpoint of DFS in Certain Patients With Clear Cell Renal Cell Carcinoma ...